Lynch Daniel
- SEC CIK
- 0001177082
No open-market purchases or sales filed in the past year.
Current role at each company
- SWTX SpringWorks Therapeutics, Inc.Directoras of Jul 2, 2025
- TSVT 2seventy bio, Inc.Directoras of Jun 15, 2023
- BLUE bluebird bio, Inc.Directoras of Nov 17, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lynch Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SWTX SpringWorks Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2025 (view filing) | Feb 20 | 4 days | Lynch DanielDirector | SSale | −47.6K | $60.22 | −$2.87M | −36.5%82.9K after | 2 lots10b5-1 |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Lynch DanielDirector | SSale | −400 | $60.00 | −$24.0K | −0.3%130.5K after | 10b5-1 |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Lynch DanielDirector | SSale | −175.0K | $54.46 | −$9.53M | −57.2%130.9K after | 3 lots10b5-1 |